Sun Pharma Advanced Research Company has reported results for third quarter ended December 31, 2013.
The company has reported net profit of Rs 30.97 crore for the quarter as compared to a net loss of Rs 24.09 crore for the same quarter in the previous year. Total income from operations of the company has increased around 15 fold at Rs 62.95 crore for quarter under review as compared to Rs 4.22 crore for the quarter ended December 31, 2012.
SPARC is an international pharmaceutical company engaged in research and development of drugs and delivery systems.